Fibronectin/α5 Integrin Contribute to Hypertension-Associated Arterial Ageing and Calcification through Affecting BMP2/MGP Imbalance and Enhancing Vascular Smooth Muscle Cell Phenotypic Transformation.

INTRODUCTION: Hypertension can accelerate and aggravate the process of arterial ageing and calcification. However, the mechanism behind has yet to be well elucidated. METHODS: Here, we monitored the dynamic changes of fibronectin (FN)/α5 integrin, bone morphogenetic protein 2/matrix Gla protein (BMP2/MGP), and Runx2 in the aorta of spontaneously hypertensive rats (SHRs) and thoracic aortic vascular smooth muscle cells (VSMCs), also the phenotypic transformation of VSMCs during the process of arterial ageing and calcification. Further, study on arterial ageing and calcification through antagonist experiments at the molecular level was explored. RESULTS: We found extracellular FN and its α5 integrin receptor expressions were positively associated with arterial ageing and calcification in SHR during ageing, as well in VSMCs from SHR in vitro. Integrin receptor inhibitor of GRGDSP would delay this arterial ageing and calcification process. Moreover, the elevated FN and α5 integrin receptor expression evoked the disequilibrium of BMP2/MGP, where the expression of BMP2, a potent osteogenic inducer, increased while MGP, a calcification inhibitor, decreased. Furthermore, it was followed by the upregulation of Runx2 and the phenotypic transformation of VSMCs from the contractile phenotype into the osteoblast-like cells. Notably, BMP2 antagonist of rmNoggin was sufficient to ameliorate the ageing and calcification process of VSMCs and exogenous BMP2-adding accelerate and aggregate the process. CONCLUSION: Our study revealed that hypertension-associated arterial ageing and calcification might be a consequence that hypertension up-regulated FN and its high binding affinity integrin α5 receptor in the aortic wall, which in turn aggravated the imbalance of BMP2/MGP, promoted the transcription of Runx2, and induced the phenotypic transformation of VSMCs from the contractile phenotype into the osteoblast-like cells. Our study would provide insights into hypertension-associated arterial ageing and calcification and shed new light on the control of arterial calcification, especially for those with hypertension.

Greenhouse Gas Emissions of Western Canadian Natural Gas: Proposed Emissions Tracking for Life Cycle Modeling.

Natural gas (NG) produced in Western Canada is a major and growing source of Canada's energy and greenhouse gas (GHG) emissions portfolio. Despite recent progress, there is still only limited understanding of the sources and drivers of Western Canadian greenhouse gas (GHG) emissions. We conduct a case study of a production facility based on Seven Generation Energy Ltd.'s Western Canadian operations and an upstream NG emissions intensity model. The case study upstream emissions intensity is estimated to be 3.1-4.0 gCO2e/MJ NG compared to current best estimates of British Columbia (BC) emissions intensities of 6.2-12 gCO2e/MJ NG and a US average estimate of 15 gCO2e/MJ. The analysis reveals that compared to US studies, public GHG emissions data for Western Canada is insufficient as current public data satisfies only 50% of typical LCA model inputs. Company provided data closes most of these gaps (∼80% of the model inputs). We recommend more detailed data collection and presentation of government reported data such as a breakdown of vented and fugitive methane emissions by source. We propose a data collection template to facilitate improved GHG emissions intensity estimates and insight about potential mitigation strategies.

The efficacy and mechanism of dexmedetomidine in myocardial apoptosis via the renin-angiotensin-aldosterone system.

INTRODUCTION: Pharmacological preconditioning limits myocardial infarct size after ischemia/reperfusion. Dexmedetomidine is an α2-adrenergic receptor agonist used in anesthesia that may have cardioprotective properties against ischemia/reperfusion injury. We investigated whether dexmedetomidine induces cardioprotection against myocardial apoptosis injury. METHODS: In order to assess the role of dexmedetomidine on myocardial apoptosis, we established a grave scalding rat model. Blood and myocardial tissue from the ventriculus sinister were harvested, then troponin, myocardial apoptosis, and expression of caspase-12, GRP78, and CHOP were assessed. RESULTS: Dexmedetomidine significantly reduced myocardial apoptosis, improved functional recovery, and reversed myocardial injury induced by grave scalding. The heart rate in the five groups studied was significantly different (p < 0.05). The number of buffy-stained nucleoli in the myocardial cell was highest in the simple scald group. The expression of caspase-12 obviously increased in the simple scald group. The expression of GRP78 and CHOP increased in the simple scald and scald and 50 µg/kg dexmedetomidine groups (p < 0.05). CONCLUSIONS: The results show that dexmedetomidine (DEX) produces cardioprotection against myocardial apoptosis injury. DEX is not only a useful sedative, but also plays a pivotal role in anesthetic cardioprotection. The potential benefits of DEX protection in high risk cardiovascular patients undergoing surgery are enormous.

A Life Cycle Assessment of integrated dairy farm-greenhouse systems in British Columbia.

The purpose of this study was to evaluate the anticipated environmental benefits from integrating a dairy farm and a greenhouse; the integration is based on anaerobic digestion of manures to produce biogas energy, biogenic CO2, and digested slurry. A full Life Cycle Assessment (LCA) has been conducted on six modeled cases applicable in British Columbia, to evaluate non-renewable energy consumption, climate change, acidification, eutrophication, respiratory effects and human toxicity. Compared to conventional practice, an integrated system has the potential to nearly halve eutrophication and respiratory effects caused by inorganic emissions and to reduce non-renewable energy consumption, climate change, and acidification by 65-90%, while respiratory effects caused by organic emissions become negative as co-products substitute for other materials. Co-digestion of other livestock manures, greenhouse plant waste, or food and food processing waste with dairy manure can further improve the performance of the integrated system.